A new study has investigated the effects of small but finite inertia on the propulsion of micro- and nano-scale swimming machines. Scientists have found that the direction of propulsion made possible by such inertia is opposite to that induced by a viscoelastic fluid. The findings could help to optimize the design of swimming machines to improve their mobility in medical applications.
Cancerous tumors protect themselves by tricking...
A special class of tiny gold particles can easily slip through cell membranes, making them good...
Scientists have designed a new self-assembling...
Bacterial infections usually announce themselves with pain and fever but often can be defeated with antibiotics—and then there are those that are sneaky and hard to beat. Now, scientists have built a new weapon against such pathogens in the form of tiny DNA pyramids. Published in ACS Applied Materials & Interfaces, their study found the nanopyramids can flag bacteria and kill more of them than medicine alone.
Federal regulators want to hear from companies using engineered micro-particles in their products, part of an effort to stay abreast of the growing field of nanotechnology. The U.S. Food and Drug Administration issued final recommendations Tuesday for companies using nanotechnology in products regulated by the government, which can include medical therapies, food and cosmetics.
Current drug delivery systems used to administer chemotherapy to cancer patients typically release a constant dose of the drug over time, but a new study challenges this "slow and steady" approach and offers a novel way to locally deliver the drugs "on demand," as reported in the Proceedings of the National Academy of Sciences.
Nanoengineers at UC San Diego have developed a nanoshell to protect foreign enzymes used to starve cancer cells as part of chemotherapy. Enzymes are naturally smart machines that are responsible for many complex functions and chemical reactions in biology. However, despite their huge potential, their use in medicine has been limited by the immune system, which is designed to attack foreign intruders.
Nanopores may one day lead a revolution in DNA sequencing. By sliding DNA molecules one at a time through tiny holes in a thin membrane, it may be possible to decode long stretches of DNA at lightning speeds. Scientists, however, haven’t quite figured out the physics of how polymer strands like DNA interact with nanopores.
Researchers have developed nanoparticles that not only bypass the body’s defence system, but also find their way to the diseased cells. The procedure uses fragments from a particular type of antibody that only occurs in camels and llamas. The small particles were even successful under conditions which are very similar to the situation within potential patients’ bodies.
One of the defining features of cells is their membranes. Each cell’s repository of DNA and protein-making machinery must be kept stable and secure from invaders and toxins. Scientists have attempted to replicate these properties, but, despite decades of research, even the most basic membrane structures, known as vesicles, still face many problems when made in the laboratory.
Scientists in Switzerland have invented a molecule that can easily and quickly show how much drug is in a patient’s system. All that is needed to perform accurate measurements is a conventional digital camera. The result of innovative protein engineering and organic chemistry, the molecule has been shown to work on a range of common drugs for cancer, epilepsy and immunosuppression.
A new nanoparticle platform developed in California increases the efficiency of drug delivery and allows excess particles to be washed away. A simple etching technique using biocompatible chemicals rapidly disassembles and removes the silver nanoparticles outside living cells. This method leaves only the intact nanoparticles for imaging or quantification, revealing which cells have been targeted and how much each cell internalized.
Short, customized carbon nanotubes have the potential to deliver drugs to pancreatic cancer cells and destroy them from within, according to researchers at Rice Univ. and the Univ. of Texas MD Anderson Cancer Center. Pristine nanotubes produced through a new process developed at Rice can be modified to carry drugs to tumors through gaps in blood-vessel walls that larger particles cannot fit through.
The first preclinical study of a new Rice Univ.-developed anticancer technology found that a novel combination of existing clinical treatments can instantaneously detect and kill only cancer cells without harming surrounding normal organs. The research reports that Rice’s “quadrapeutics” technology was 17 times more efficient than conventional chemoradiation therapy against aggressive, drug-resistant head and neck tumors.
A team of researchers has successfully tracked single molecules inside living cells with carbon nanotubes. Through this new method, the researchers found that cells stir their interiors using the same motor proteins that serve in muscle contraction. The study, which sheds new light on biological transport mechanisms in cells, appears in Science.
Biomedical engineering researchers have developed daisy-shaped, nanoscale structures that are made predominantly of anticancer drugs and are capable of introducing a “cocktail” of multiple drugs into cancer cells. The researchers are all part the joint biomedical engineering program at North Carolina State Univ. and the Univ. of North Carolina at Chapel Hill.
Using molecules of DNA like an architectural scaffold, Arizona State Univ. scientists, in collaboration with colleagues at the Univ. of Michigan, have developed a 3-D artificial enzyme cascade that mimics an important biochemical pathway that could prove important for future biomedical and energy applications.
Photodynamic therapy (PDT) is an effective treatment for easily accessible tumors such as oral and skin cancer. But the procedure, which uses lasers to activate special drugs called photosensitizing agents, isn’t adept at fighting cancer deep inside the body. That could change because of a new technology that could bring PDT into areas of the body which were previously inaccessible.
Massachusetts Institute of Technology researchers have devised a novel cancer treatment that destroys tumor cells by first disarming their defenses, then hitting them with a lethal dose of DNA damage. In studies with mice, the research team showed that this one-two punch, which relies on a nanoparticle that carries two drugs and releases them at different times, dramatically shrinks lung and breast tumors.
A research team using tunable luminescent nanocrystals as tags to advance medical and security imaging have successfully applied them to high-speed scanning technology and detected multiple viruses within minutes. The research builds on the team's earlier success in developing a way to control the length of time light from a luminescent nanocrystal lingers.
An interdisciplinary team of scientists in Belgium has developed a new technique to examine how proteins interact with each other at the level of a single HIV viral particle. The technique allows scientists to study the life-threatening virus in detail and makes screening potential anti-HIV drugs quicker and more efficient. The technique can also be used to study other diseases.
Medical nanoparticles need to be eventually eliminated from the body after they complete their task. Researchers have developed a new method to analyze and characterize this process of nanoparticle “disassembly”, as a necessary step in translating nanoparticles into clinical use. The technique involves the use of Förster resonance energy transfer, or FRET, as a sort of molecular ruler to measure distance at small scales.
A team at Purdue Univ. has used gold nanoparticles to target and bind to fragments of genetic material known as BRCA1 messenger RNA splice variants, which can indicate the presence and stage of breast cancer. The number of these synthetic DNA “tails” in a cell can be determined in a living cell by examining the specific signal that light produces when it interacts with the gold nanoparticles.
It's a familiar trope in science fiction: In enemy territory, activate your cloaking device. And real-world viruses use similar tactics to make themselves invisible to the immune system. Now scientists at Harvard Univ.'s Wyss Institute for Biologically Inspired Engineering have mimicked these viral tactics to build the first DNA nanodevices that survive the body's immune defenses.
Physicist Wei Chen at Univ. of Texas at Arlington’s Center for Security Advances Via Applied Nanotechnology was testing a copper-cysteamine complex created in his laboratory when he discovered unexplained decreases in its luminescence, or light emitting power, over a time-lapse exposure to x-rays. Further testing work revealed that the “Cu-Cy” nanoparticles, when combined with x-ray exposure, significantly slowed tumor growth in studies.
A team of scientists, led by physicist Amir Yacoby of Harvard Univ., has developed a magnetic resonance imaging (MRI) system that can produce nanoscale images, and may one day allow researchers to peer into the atomic structure of individual molecules. Though not yet precise enough to capture atomic-scale images of a single molecule, the system already has been used to capture images of single electron spins.
When considering potential drug delivery vehicles, liposomes are an important option and have already been approved for use with a number of therapeutic formulations. Liposomes are comprised of phospholipids and may be single- or multi-layered, can be produced in different sizes and have a hydrophilic interior and hydrophobic shell. They are biodegradable, non-toxic and capable of encapsulating both hydrophilic and hydrophobic materials.
Nanotechnology has unlocked new pathways for targeted drug delivery, including the use of nanocarriers that can transport cargoes of small-molecule therapeutics to specific locations in the body. Researchers have recently demonstrated that processing can have significant influence on the size of nanocarriers for targeted drug delivery. It was previously assumed that once a nanocarrier is created, it maintains its size and shape anywhere.
- Page 1